His primary areas of study are Alzheimer's disease, Pathology, Internal medicine, Dementia and Neuroscience. His work carried out in the field of Alzheimer's disease brings together such families of science as Biomarker, Predictive value of tests and Retrospective cohort study. His work on Cerebrospinal fluid, Tau protein and Cohort study as part of general Pathology study is frequently linked to Hyperphosphorylation, bridging the gap between disciplines.
The various areas that Michael Ewers examines in his Internal medicine study include Gastroenterology, Endocrinology and Cardiology. His research in Dementia intersects with topics in Voxel, Magnetic resonance imaging, Neuropsychology and Atrophy. His studies deal with areas such as Voxel-based morphometry, Feature and Audiology as well as Neuroscience.
Michael Ewers mostly deals with Disease, Internal medicine, Pathology, Neuroscience and Dementia. His Disease research incorporates themes from Cognition, Immunology and Atrophy. His research investigates the link between Internal medicine and topics such as Endocrinology that cross with problems in Amyloidosis.
His Pathology research is multidisciplinary, incorporating elements of White matter and Hyperintensity. He has researched Dementia in several fields, including Apolipoprotein E, Neurology, Neurodegeneration and Gerontology. His research integrates issues of Predictive value of tests, Psychiatry, Cognitive disorder and Audiology in his study of Alzheimer's disease.
Michael Ewers mainly investigates Disease, Internal medicine, Cognition, Amyloid and Dementia. His Disease study combines topics in areas such as Precision medicine, Neuroscience and Atrophy. His Internal medicine research includes elements of Endocrinology and Oncology.
His Amyloid research entails a greater understanding of Pathology. His work deals with themes such as White matter, Hyperintensity and Diffusion MRI, which intersect with Pathology. The Dementia study combines topics in areas such as Hazard ratio, Confidence interval, Hippocampal formation, Apolipoprotein E and Neurology.
Michael Ewers mainly focuses on Internal medicine, Disease, Cognition, TREM2 and Cognitive decline. He works in the field of Internal medicine, focusing on Biomarker in particular. His Biomarker research integrates issues from Endocrinology, Cerebrospinal fluid, Immune system, Beta and Amyloidosis.
Michael Ewers works mostly in the field of Disease, limiting it down to concerns involving Neuroscience and, occasionally, Tau pathology and SNP. Michael Ewers works mostly in the field of Cognition, limiting it down to topics relating to Oncology and, in certain cases, Sample size determination, Atrophy, Fluorodeoxyglucose and Clinical trial, as a part of the same area of interest. His study on Cognitive decline is covered under Dementia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen.
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger;Michael Ewers;Tuula Pirttila;Raymond Zinkowski.
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance
Michael Ewers;Michael Ewers;Cathal Walsh;John Q. Trojanowski;Leslie M. Shaw.
Neurobiology of Aging (2012)
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.
Katrin Jekel;Marinella Damian;Carina Wattmo;Lucrezia Hausner.
Alzheimer's Research & Therapy (2015)
Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
Harald Hampel;Michael Ewers;Katharina Bürger;Peter Annas.
The Journal of Clinical Psychiatry (2009)
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Michael Ewers;Reisa A. Sperling;Reisa A. Sperling;William E. Klunk;Michael W. Weiner;Michael W. Weiner.
Trends in Neurosciences (2011)
Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease.
Claudia Plant;Stefan J. Teipel;Stefan J. Teipel;Annahita Oswald;Christian Böhm.
Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance
Yaakov Stern;Eider M. Arenaza-Urquijo;David Bartrés-Faz;Sylvie Belleville.
Alzheimers & Dementia (2020)
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
Stefan J. Teipel;Christine Born;Michael Ewers;Arun L.W. Bokde.
Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive Impairment
Zhenyu Zhong;Michael Ewers;Stefan Teipel;Katharina Bürger.
Archives of General Psychiatry (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: